Back to User profile » Dr Kavita Nair

Papers published by Dr Kavita Nair:


Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

Foley JF, Nair KV, Vollmer T, Stephenson JJ, Niecko T, Agarwal SS, Watson C

Patient Preference and Adherence 2017, 11:1035-1048

Published Date: 16 June 2017

Incremental increases in economic burden parallels cardiometabolic risk factors in the US

McQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJ

Diabetes, Metabolic Syndrome and Obesity 2016, 9:233-241

Published Date: 2 August 2016

The cost of inpatient death associated with acute coronary syndrome

Page II RL, Ghushchyan V, Van Den Bos J, Gray TJ, Hoetzer GL, Bhandary D, Nair KV

Vascular Health and Risk Management 2016, 12:13-21

Published Date: 3 February 2016

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap

Page RL 2nd, Ghushchyan V, Allen RR, Roper L, Beck D, Johnathan BH, Frech-Tamas F, Chan W, McQueen RB, Nair KV

Drug, Healthcare and Patient Safety 2012, 4:67-74

Published Date: 10 July 2012

An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures

Pesa JA, Van Den Bos J, Gray T, Hartsig C, McQueen RB, Saseen JJ, Nair KV

Patient Preference and Adherence 2012, 6:63-72

Published Date: 18 January 2012

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey

Nair KV, Belletti D, Doyle J, Allen R, McQueen R, Saseen J, Griend J, Patel J, McQueen A, Jan S

Patient Preference and Adherence 2011, 5:195-206

Published Date: 29 April 2011